STE · 10-Q · 2026Q3 · Full report

North Carolina Chemistry Consolidation

STERIS plc · 2026-11-05 · Importance 52 · Surprise 42 · In source text

The Fiscal 2027 Manufacturing Restructuring Plan will consolidate formulated-chemistry manufacturing and distribution at a new North Carolina Center of Excellence and close facilities in St. Louis, Missouri, and Plymouth, Minnesota. The plan is expected to incur $55 million to $70 million of pretax charges, including $40 million to $50 million cash costs and $15 million to $20 million noncash charges, with completion anticipated during fiscal 2030; $1.0 million had been recorded. The Fiscal 2027 Portfolio and Organizational Optimization Plan anticipates approximately $45 million of charges, including $10 million cash and $35 million noncash, and is expected to be substantially complete by fiscal year-end 2028; $25.0 million had been recorded, including $6.3 million in cost of revenues. The two plans contributed to $25.5 million of restructuring charges in the six months ended September 30, 2026, compared with $2.9 million a year earlier; the earlier Fiscal 2025 Plan eliminated approximately 300 positions and recorded $109.5 million of cumulative expense.

Key facts

• STERIS expects to invest approximately $600 million to build a new Center of Excellence facility in North Carolina under its Fiscal 2027 Manufacturing Restructuring Plan. source
• STERIS expects $55 million to $70 million of pre-tax charges for its Fiscal 2027 Manufacturing Restructuring Plan, including $40 million to $50 million of cash expenditures and $15 million to $20 million of non-cash charges; completion is anticipated during fiscal 2030. source
• STERIS announced on August 5, 2026, a plan to consolidate formulated-chemistry manufacturing and distribution at a new Center of Excellence in North Carolina, intended to accelerate innovation, expand capacity and optimize its U.S. network. source
• STERIS's North Carolina manufacturing restructuring plan anticipates closing chemistry manufacturing and distribution facilities in St. Louis, Missouri, and Plymouth, Minnesota. source
• STERIS identifies the risk that the expected benefits, charges, and cash expenditures from the North Carolina Center of Excellence and related facility consolidation plan may be inaccurate or may not be realized on anticipated timelines or at all. source
• STERIS recorded $1.0 million of total restructuring expense for the Fiscal 2027 Manufacturing Restructuring Plan. source

Impact estimates